Channel News AsiaSandoz launches ZarxioTM (filgrastim-sndz), the first biosimilar in the United ...MarketWatch(Thomson Reuters ONE via COMTEX) -- Novartis International AG / Sandoz launches ZarxioTM (filgrastim-sndz), the first biosimilar in the United States . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for ...Appeals court says copycat cancer drug can go on saleColumbus DispatchCourt Decision Could Allow Novartis To Sell Copy of Amgen's NeupogenNasdaqJudge's ruling allows Sandoz to begin marketing its biosimilar ZarxioMedical Marketing and MediaPharmaTimes -Seeking Alphaall 27 news articles »